EXHIBIT 99.1
JOINT FILING AGREEMENT
The undersigned hereby agree that the statement on Schedule 13D with respect to the Common Stock of Navidea Biopharmaceuticals, Inc. dated as of March 8, 2016 is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Dated: March 9, 2016
| PLATINUM PARTNERS VALUE ARBITRAGE FUND L.P. | ||||
| By: | Platinum Management (NY) LLC, as Investment Manager | |||
| By: | /s/ Joseph SanFilippo | |||
| Name: | Joseph SanFilippo | |||
| Title: | Chief Financial Officer | |||
| PLATINUM MANAGEMENT (NY) LLC | ||||
| By: | /s/ Joseph SanFilippo | |||
| Name: | Joseph SanFilippo | |||
| Title: | Chief Financial Officer | |||
| PLATINUM PARTNERS LIQUID OPPORTUNITY MASTER FUND LP | ||||
| By: | Platinum Liquid Opportunity Management (NY) LLC, as Investment Manager | |||
| By: | /s/ Joseph SanFilippo | |||
| Name: | Joseph SanFilippo | |||
| Title: | Chief Financial Officer | |||
| PLATINUM LIQUID OPPORTUNITY MANAGEMENT (NY) LLC | ||||
| By: | /s/ Joseph SanFilippo | |||
| Name: | Joseph SanFilippo | |||
| Title: | Chief Financial Officer | |||
| /s/ Mark Nordlicht |
| MARK NORDLICHT |